Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progressioan

被引：0

作者：

Mikhail G Dozmorov

Joseph T Azzarello

Jonathan D Wren

Kar-Ming Fung

Qing Yang

Jeffrey S Davis

Robert E Hurst

Daniel J Culkin

Trevor M Penning

Hsueh-Kung Lin

机构：

[1] Oklahoma Medical Research Foundation,Arthritis & Clinical Immunology Program

[2] University of Oklahoma Health Sciences Center,Department of Urology

[3] University of Oklahoma Health Sciences Center,Department of Physiology

[4] University of Oklahoma Health Sciences Center,Department of Pathology

[5] Oklahoma City Department of Veterans Affairs Medical Center,Department of Biochemistry and Molecular Biology

[6] University of Oklahoma Health Sciences Center,Center of Excellence in Environmental Toxicology, Department of Pharmacology

[7] University of Pennsylvania School of Medicine,undefined

来源：

BMC Cancer | / 10卷

关键词：

Vascular Endothelial Growth Factor; Androgen Receptor; Vascular Endothelial Growth Factor Expression; LNCaP Cell; Vascular Endothelial Growth Factor mRNA Expression;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progressioan
Dozmorov, Mikhail G.
Azzarello, Joseph T.
Wren, Jonathan D.
Fung, Kar-Ming
Yang, Qing
Davis, Jeffrey S.
Hurst, Robert E.
Culkin, Daniel J.
Penning, Trevor M.
Lin, Hsueh-Kung
BMC CANCER, 2010, 10
[2] AKR1C3 as a target in castrate resistant prostate cancer
Adeniji, Adegoke O.
Chen, Mo
Penning, Trevor M.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 137 : 136 - 149
[3] Lipid degradation promotes prostate cancer cell survival
Itkonen, Harri M.
Brown, Michael
Urbanucci, Alfonso
Tredwell, Gregory
Lau, Chung Ho
Barfeld, Stefan
Hart, Claire
Guldvik, Ingrid J.
Takhar, Mandeep
Heemers, Hannelore V.
Erho, Nicholas
Bloch, Katarzyna
Davicioni, Elai
Derua, Rita
Waelkens, Etienne
Mohler, James L.
Clarke, Noel
Swinnen, Johan V.
Keun, Hector C.
Rekvig, Ole P.
Mills, Ian G.
ONCOTARGET, 2017, 8 (24) : 38264 - 38275
[4] AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
Tian, Yuantong
Zhao, Lijing
Zhang, Haitao
Liu, Xichun
Zhao, Lijuan
Zhao, Xuejian
Li, Yi
Li, Jing
DIAGNOSTIC PATHOLOGY, 2014, 9
[5] Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells
Doig, Craig L.
Battaglia, Sebastiano
Khanim, Farhat L.
Bunce, Christopher M.
Campbell, Moray J.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 155 : 47 - 55
[6] Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation
Sun, Shao-Qian
Gu, Xiaobin
Gao, Xian-Shu
Li, Yi
Yu, Hongliang
Xiong, Wei
Yu, Hao
Wang, Wen
Li, Yingbo
Teng, Yingqi
Zhou, Demin
ONCOTARGET, 2016, 7 (30) : 48050 - 48058
[7] Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents
Joshi, Gaurav
Singh, Pankaj Kumar
Negi, Arvind
Rana, Anil
Singh, Sandeep
Kumar, Raj
CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 240 : 120 - 133
[8] Mechanisms of Prostate Cancer Cell Survival After Inhibition of AR Expression
Cohen, Michael B.
Rokhlin, Oskar W.
JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 106 (03) : 363 - 371
[9] Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival
C Sun
Y Shi
L L Xu
C Nageswararao
L D Davis
T Segawa
A Dobi
D G McLeod
S Srivastava
Oncogene, 2006, 25 : 3905 - 3913
[10] Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival
Sun, C.
Shi, Y.
Xu, L. L.
Nageswararao, C.
Davis, L. D.
Segawa, T.
Dobi, A.
McLeod, D. G.
Srivastava, S.
ONCOGENE, 2006, 25 (28) : 3905 - 3913

← 1 2 3 4 5 →